Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure

Archives of Cardiovascular Diseases

Volumn 107, Issue 1, 2014, Pages 21-32

  Juillière, Yves ^a   Suty Selton, Christine ^a   Riant, Elisabeth ^a   Darracq, Jean Pierre ^b   Dellinger, Arnaud ^c   Labarre, Jean Philippe ^d   Druelle, Justine ^e   Mulak, Geneviève ^f   Danchin, Nicolas ^g   Jourdain, Patrick ^h  

^a Heart Failure and Valvular Heart Diseases Unit   (France)

^b Centre Hospitalier Samuel Pozzi   (France)

^c William Morey Hospital   (France)

^d Clinique Château de Vernhes   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f French Society of Cardiology   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h School of Heart   (France)

Author keywords

Age; Cardiovascular drugs; Heart failure with preserved ejection fraction; Left ventricular ejection fraction; Systolic heart failure

Indexed keywords

AGE; ÂGE; CARDIOVASCULAR DRUGS; FRACTION D'ÉJECTION VENTRICULAIRE GAUCHE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; INSUFFISANCE CARDIAQUE AVEC FRACTION D'ÉJECTION PRÉSERVÉE; INSUFFISANCE CARDIAQUE SYSTOLIQUE; LEFT VENTRICULAR EJECTION FRACTION; MÉDICAMENTS CARDIOVASCULAIRES; SYSTOLIC HEART FAILURE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; FRANCE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84895077213     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2013.11.001     Document Type: Article

References (35)

1. L. Bonneux, J.J. Barendregt, and K. Meeter et al. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure Am J Public Health 84 1994 20 28
2. H. Eriksson Heart failure: a growing public health problem J Intern Med 237 1995 135 141
3. H. Cooper, K. Booth, and S. Fear et al. Chronic disease patient education: lessons from meta-analyses Patient Educ Couns 44 2001 107 117
4. T. Groves, and E.H. Wagner High quality care for people with chronic diseases BMJ 330 2005 609 610
5. F.A. McAlister, S. Stewart, and S. Ferrua et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819
6. R. Roccaforte, C. Demers, and F. Baldassarre et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis Eur J Heart Fail 7 2005 1133 1144
7. Report of a WHO Working Group. Therapeutic patient education: continuing education programmes for health care providers in the field of prevention of chronic diseases. Available at: http://www.euro.who.int/--data/assets/pdf-file/ 0007/145294/E63674.pdf
8. L. Gask Role of specialists in common chronic diseases BMJ 330 2005 651 653
9. P. Glasziou, L. Irwig, and D. Mant Monitoring in chronic disease: a rational approach BMJ 330 2005 644 648
10. C.O. Phillips, R.M. Singa, and H.R. Rubin et al. Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis Eur J Heart Fail 7 2005 333 341
11. K. Dickstein, A. Cohen-Solal, and G. Filippatos et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
12. Y. Juilliere, P. Jourdain, and J. Roncalli et al. Therapeutic education for cardiac failure patients: the I-care programme Arch Mal Coeur Vaiss 98 2005 300 307
13. Y. Juilliere, P. Jourdain, and C. Suty-Selton et al. Therapeutic patient education and all-cause mortality in patients with chronic heart failure: a propensity analysis Int J Cardiol 168 2013 388 395
14. Y. Juilliere, P. Jourdain, and J. Roncalli et al. Therapeutic education unit for heart failure: setting-up and difficulties. Initial evaluation of the I-CARE programme Arch Cardiovasc Dis 102 2009 19 27
15. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
16. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 1810 1852
17. D. Logeart, R. Isnard, and M. Resche-Rigon et al. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study Eur J Heart Fail 15 2013 465 476
18. J.G. Cleland, A. Cohen-Solal, and J.C. Aguilar et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 2002 1631 1639
19. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. Baseline characteristics of patients recruited into the CARE-HF study Eur J Heart Fail 7 2005 205 214
20. P. de Groote, R. Isnard, and P. Assyag et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey Eur J Heart Fail 9 2007 1205 1211
21. P. de Groote, R. Isnard, and P. Clerson et al. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme Eur J Heart Fail 11 2009 85 91
22. M. Packer, P.A. Poole-Wilson, and P.W. Armstrong et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group Circulation 100 1999 2312 2318
23. D.D. Sin, and F.A. McAlister The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11 942 elderly patients with heart failure Am J Med 113 2002 650 656
24. D.N. Juurlink, M.M. Mamdani, and D.S. Lee et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study N Engl J Med 351 2004 543 551
25. M. Komajda, F. Follath, and K. Swedberg et al. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474
26. F.A. Masoudi, S.S. Rathore, and Y. Wang et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction Circulation 110 2004 724 731
27. K. Swedberg, M. Komajda, and M. Bohm et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
28. A. Cohen Solal, I. Leurs, and P. Assyag et al. Optimization of heart failure medical treatment after hospital discharge according to left ventricular ejection fraction: the FUTURE survey Arch Cardiovasc Dis 105 2012 355 365
29. D. Houpe, M. Peltier, and A. Cohen-Solal et al. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year Int J Cardiol 103 2005 286 292
30. M.J. Lenzen, E. Boersma, and W.J. Reimer et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur Heart J 26 2005 2706 2713
31. M. Komajda, O. Hanon, and M. Hochadel et al. Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I Eur Heart J 28 2007 1310 1318
32. M.J. Lenzen, W.J. Scholte op Reimer, and E. Boersma et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220
33. T.E. Owan, D.O. Hodge, and R.M. Herges et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
34. J.G. Cleland, M. Tendera, and J. Adamus et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2340
35. B.M. Massie, P.E. Carson, and J.J. McMurray et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467